SEC 13F Intelligence

Trv GP III, LLC / NRIX

Trv GP III, LLC’s Nurix Therapeutics Inc Position

Does Trv GP III, LLC own Nurix Therapeutics Inc (NRIX)? Not currently — the last reported position was 1.92M shares worth $24M in Q2 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$24M
Q2 2022
Shares
1.92M
% of Portfolio
+9.96%
Quarters Held
8
position exited

Position History NRIX

Reported value by quarter
Q3 ’20: $189MQ3 ’20Q4 ’20: $178MQ4 ’20Q1 ’21: $140MQ1 ’21Q2 ’21: $91MQ2 ’21Q3 ’21: $73MQ3 ’21Q4 ’21: $70MQ4 ’21Q1 ’22: $27MQ1 ’22Q2 ’22: $24MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20221.92M$24M+9.96%
Q1 20221.92M$27M+7.31%
Q4 20212.42M$70M+17.55%
Q3 20212.42M$73M+13.78%
Q2 20213.42M$91M+15.85%
Q1 20214.51M$140M+17.73%
Q4 20205.42M$178M+15.31%
Q3 20205.42M$189M+15.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP III, LLC’s full portfolio or all institutional holders of NRIX.